252 related articles for article (PubMed ID: 28107189)
1. Docosahexaenoic acid and disulfiram act in concert to kill cancer cells: a mutual enhancement of their anticancer actions.
Jiao Y; Hannafon BN; Zhang RR; Fung KM; Ding WQ
Oncotarget; 2017 Mar; 8(11):17908-17920. PubMed ID: 28107189
[TBL] [Abstract][Full Text] [Related]
2. Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1.
Jiao Y; Watts T; Xue J; Hannafon B; Ding WQ
BMC Cancer; 2018 Oct; 18(1):1042. PubMed ID: 30367621
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid (DHA)-induced heme oxygenase-1 attenuates cytotoxic effects of DHA in vascular smooth muscle cells.
Stulnig G; Frisch MT; Crnkovic S; Stiegler P; Sereinigg M; Stacher E; Olschewski H; Olschewski A; Frank S
Atherosclerosis; 2013 Oct; 230(2):406-13. PubMed ID: 24075775
[TBL] [Abstract][Full Text] [Related]
4. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.
Kim JY; Cho Y; Oh E; Lee N; An H; Sung D; Cho TM; Seo JH
Cancer Lett; 2016 Aug; 379(1):39-48. PubMed ID: 27238567
[TBL] [Abstract][Full Text] [Related]
5. Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.
Huang H; Liao Y; Liu N; Hua X; Cai J; Yang C; Long H; Zhao C; Chen X; Lan X; Zang D; Wu J; Li X; Shi X; Wang X; Liu J
Oncotarget; 2016 Jan; 7(3):2796-808. PubMed ID: 26625200
[TBL] [Abstract][Full Text] [Related]
6. PPARalpha signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells.
Tuller ER; Brock AL; Yu H; Lou JR; Benbrook DM; Ding WQ
Biochem Pharmacol; 2009 May; 77(9):1480-6. PubMed ID: 19426685
[TBL] [Abstract][Full Text] [Related]
7. Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma.
Lun X; Wells JC; Grinshtein N; King JC; Hao X; Dang NH; Wang X; Aman A; Uehling D; Datti A; Wrana JL; Easaw JC; Luchman A; Weiss S; Cairncross JG; Kaplan DR; Robbins SM; Senger DL
Clin Cancer Res; 2016 Aug; 22(15):3860-75. PubMed ID: 27006494
[TBL] [Abstract][Full Text] [Related]
8. Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer.
Wu X; Xue X; Wang L; Wang W; Han J; Sun X; Zhang H; Liu Y; Che X; Yang J; Wu C
Eur J Pharmacol; 2018 May; 827():1-12. PubMed ID: 29547841
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of matrix metalloproteinase-9 expression by docosahexaenoic acid mediated by heme oxygenase 1 in 12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 human breast cancer cells.
Chen HW; Chao CY; Lin LL; Lu CY; Liu KL; Lii CK; Li CC
Arch Toxicol; 2013 May; 87(5):857-69. PubMed ID: 23288142
[TBL] [Abstract][Full Text] [Related]
10. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
[TBL] [Abstract][Full Text] [Related]
11. Disulfiram's Anticancer Activity: Evidence and Mechanisms.
Jiao Y; Hannafon BN; Ding WQ
Anticancer Agents Med Chem; 2016; 16(11):1378-1384. PubMed ID: 27141876
[TBL] [Abstract][Full Text] [Related]
12. Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer.
Allensworth JL; Evans MK; Bertucci F; Aldrich AJ; Festa RA; Finetti P; Ueno NT; Safi R; McDonnell DP; Thiele DJ; Van Laere S; Devi GR
Mol Oncol; 2015 Jun; 9(6):1155-68. PubMed ID: 25769405
[TBL] [Abstract][Full Text] [Related]
13. A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone.
Altenburg JD; Bieberich AA; Terry C; Harvey KA; Vanhorn JF; Xu Z; Jo Davisson V; Siddiqui RA
BMC Cancer; 2011 Apr; 11():149. PubMed ID: 21510869
[TBL] [Abstract][Full Text] [Related]
14. Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors.
Choi SA; Choi JW; Wang KC; Phi JH; Lee JY; Park KD; Eum D; Park SH; Kim IH; Kim SK
Neuro Oncol; 2015 Jun; 17(6):810-21. PubMed ID: 25378634
[TBL] [Abstract][Full Text] [Related]
15. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
Sun T; Yang W; Toprani SM; Guo W; He L; DeLeo AB; Ferrone S; Zhang G; Wang E; Lin Z; Hu P; Wang X
Cell Commun Signal; 2020 Mar; 18(1):36. PubMed ID: 32138738
[TBL] [Abstract][Full Text] [Related]
16. Blockade of ALDH in Cisplatin-Resistant Ovarian Cancer Stem Cells In Vitro Synergistically Enhances Chemotherapy-Induced Cell Death.
Guo F; Yang Z; Sehouli J; Kaufmann AM
Curr Oncol; 2022 Apr; 29(4):2808-2822. PubMed ID: 35448203
[TBL] [Abstract][Full Text] [Related]
17. Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts.
Newell M; Goruk S; Mazurak V; Postovit L; Field CJ
Breast Cancer Res Treat; 2019 Sep; 177(2):357-367. PubMed ID: 31236812
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of disulfiram/copper complex in the poorly-differentiated nasopharyngeal carcinoma cells via activating ClC-3 chloride channel.
Xu X; Xu J; Zhao C; Hou X; Li M; Wang L; Chen L; Chen Y; Zhu L; Yang H
Biomed Pharmacother; 2019 Dec; 120():109529. PubMed ID: 31606620
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation.
Kang KS; Wang P; Yamabe N; Fukui M; Jay T; Zhu BT
PLoS One; 2010 Apr; 5(4):e10296. PubMed ID: 20421971
[TBL] [Abstract][Full Text] [Related]
20. Anti-proliferative activity of disulfiram through regulation of the AKT-FOXO axis: A proteomic study of molecular targets.
Nasrollahzadeh A; Momeny M; Fasehee H; Yaghmaie M; Bashash D; Hassani S; Mousavi SA; Ghaffari SH
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119087. PubMed ID: 34182011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]